Literature DB >> 23255721

Synaptic and extrasynaptic plasticity in glutamatergic circuits involving dentate granule cells following chronic N-methyl-D-aspartate receptor inhibition.

Shuijin He1, Li-Rong Shao, Yu Wang, Suzanne B Bausch.   

Abstract

Chronic global N-methyl-d-aspartate receptor (NMDAR) blockade leads to changes in glutamatergic transmission. The impact of more subunit-selective NMDAR inhibition on glutamatergic circuits remains incomplete. To this end, organotypic hippocampal slice cultures were treated for 17-21 days with the high-affinity competitive antagonist d-aminophosphonovaleric acid (d-APV), the allosteric GluN2B-selective antagonist Ro25-6981, or the newer competitive GluN2A-preferring antagonist NVP-AAM077. Electrophysiological recordings from dentate granule cells revealed that chronic d-APV treatment increased, whereas chronic Ro25-6981 reduced, epileptiform event-associated large-amplitude spontaneous excitatory postsynaptic currents (sEPSC) compared with all other treatment groups, consistent with opposite effects on glutamatergic networks. Presynaptically, chronic d-APV or Ro25-6981 increased small-amplitude sEPSCs and AMPA/kainate receptor-mediated miniature EPSCs (mEPSCAMPAR) frequency. Chronic d-APV or NVP-AAM077, but not Ro25-6981, increased putative vGlut1-positive glutamatergic synapses. Postsynaptically, chronic d-APV dramatically increased mEPSCAMPAR and profoundly decreased NMDAR-mediated mEPSC (mEPSCNMDAR) measures, suggesting increased AMPAR/NMDAR ratio. Ro25-6981 decreased mEPSCAMPAR charge transfer and modestly decreased mEPSCNMDAR frequency and decay, suggesting downward scaling of AMPAR and NMDAR function without dramatically altering AMPAR/NMDAR ratio. Extrasynaptically, threo-β-benzyloxyaspartate-enhanced "tonic" NMDAR current amplitude and activated channel number estimates were significantly increased only by chronic Ro25-6981. For intrinsic excitability, action potential threshold was slightly more negative following chronic d-APV or NVP-AAM077. The predominant pro-excitatory effects of chronic d-APV are consistent with increased glutamatergic transmission and network excitability. The minor effects of chronic NVP-AAM077 on action potential threshold and synapse number are consistent with minimal effects on circuit function. The chronic Ro25-6981-induced downward scaling of synaptic AMPAR and NMDAR function is consistent with decreased postsynaptic glutamate receptors and reduced network excitability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255721      PMCID: PMC3602941          DOI: 10.1152/jn.00667.2012

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  70 in total

1.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.

Authors:  H Monyer; N Burnashev; D J Laurie; B Sakmann; P H Seeburg
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

2.  Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

Authors:  G Fischer; V Mutel; G Trube; P Malherbe; J N Kew; E Mohacsi; M P Heitz; J A Kemp
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

3.  Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex.

Authors:  C R Scherzer; G B Landwehrmeyer; J A Kerner; T J Counihan; C M Kosinski; D G Standaert; L P Daggett; G Veliçelebi; J B Penney; A B Young
Journal:  J Comp Neurol       Date:  1998-01-05       Impact factor: 3.215

4.  DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.

Authors:  K Shimamoto; B Lebrun; Y Yasuda-Kamatani; M Sakaitani; Y Shigeri; N Yumoto; T Nakajima
Journal:  Mol Pharmacol       Date:  1998-02       Impact factor: 4.436

5.  Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons.

Authors:  G Stocca; S Vicini
Journal:  J Physiol       Date:  1998-02-15       Impact factor: 5.182

6.  Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats.

Authors:  G Köhr; Y De Koninck; I Mody
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

7.  Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions.

Authors:  J Church; E J Fletcher; K Baxter; J F MacDonald
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy.

Authors:  S Sveinbjornsdottir; J W Sander; D Upton; P J Thompson; P N Patsalos; D Hirt; M Emre; D Lowe; J S Duncan
Journal:  Epilepsy Res       Date:  1993-10       Impact factor: 3.045

9.  Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus.

Authors:  E Gould; H A Cameron; B S McEwen
Journal:  J Comp Neurol       Date:  1994-02-22       Impact factor: 3.215

10.  Changing subunit composition of heteromeric NMDA receptors during development of rat cortex.

Authors:  M Sheng; J Cummings; L A Roldan; Y N Jan; L Y Jan
Journal:  Nature       Date:  1994-03-10       Impact factor: 49.962

View more
  5 in total

1.  Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways.

Authors:  W Bradley Rittase; Yu Dong; DaRel Barksdale; Zygmunt Galdzicki; Suzanne B Bausch
Journal:  Mol Cell Neurosci       Date:  2014-04-23       Impact factor: 4.314

2.  Organotypic Hippocampal Slice Cultures As a Model to Study Neuroprotection and Invasiveness of Tumor Cells.

Authors:  Urszula Grabiec; Tim Hohmann; Niels Hammer; Faramarz Dehghani
Journal:  J Vis Exp       Date:  2017-08-27       Impact factor: 1.355

3.  Colocalization of distinct NMDA receptor subtypes at excitatory synapses in the entorhinal cortex.

Authors:  Stephen Beesley; Thomas Sullenberger; Jyotsna Pilli; Saad Abbasi; Akash Gunjan; Sanjay S Kumar
Journal:  J Neurophysiol       Date:  2018-11-21       Impact factor: 2.714

4.  Synaptic plasticity in glutamatergic and GABAergic neurotransmission following chronic memantine treatment in an in vitro model of limbic epileptogenesis.

Authors:  Shuijin He; Suzanne B Bausch
Journal:  Neuropharmacology       Date:  2013-10-30       Impact factor: 5.250

5.  GluN2B but Not GluN2A for Basal Dendritic Growth of Cortical Pyramidal Neurons.

Authors:  Steffen Gonda; Jan Giesen; Alexander Sieberath; Fabian West; Raoul Buchholz; Oliver Klatt; Tim Ziebarth; Andrea Räk; Sabine Kleinhubbert; Christian Riedel; Michael Hollmann; Mohammad I K Hamad; Andreas Reiner; Petra Wahle
Journal:  Front Neuroanat       Date:  2020-11-13       Impact factor: 3.856

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.